Memantine in Behavioral Variant Frontotemporal Dementia: Negative Results

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2011-03-21

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3233/JAD-2010-101632PMID 21157021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia

  2009cited by this paper
• An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration

  2009cited by this paper
• New approaches to the treatment of frontotemporal lobar degeneration

  2008cited by this paper
• A 6‐month, open‐label study of memantine in patients with frontotemporal dementia

  2008cited by this paper
• Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.

  2007cited by this paper
• Longitudinal Tracking of FTLD: Toward Developing Clinical Trial Methodology

  2007cited by this paper
• Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer’s Disease

  2007cited by this paper
• Memantine for Behavioral Disturbances in Frontotemporal Dementia: A Case Series

  2007cited by this paper
• A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

  2006influential reference
• Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

  2006cited by this paper
• Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone

  2004cited by this paper
• Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

  2004cited by this paper
• A Longitudinal Study of Behavior in Frontotemporal Dementia and Primary Progressive Aphasia

  2004cited by this paper
• Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial

  2004cited by this paper
• Survival in frontotemporal dementia

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• The FAB: A frontal assessment battery at bedside

  2001cited by this paper
• The FAB: A frontal assessment battery at bedside

  2000cited by this paper
• Neurochemical Features of Frontotemporal Dementia

  1999cited by this paper
• Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

  1999influential reference
• Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

  1999cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• Frontotemporal Behavioral Scale

  1998cited by this paper
• Frontal Behavioral Inventory: Diagnostic Criteria for Frontal Lobe Dementi

  1997influential reference
• Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.

  1997cited by this paper
• Clinical Evaluation of Global Change in Alzheimer's Disease: Identifying Consensus

  1996cited by this paper
• Theα2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Relatives of the impaired elderly: correlates of feelings of burden.

  1980influential reference
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975influential reference

• Effect of long‐term treatment with memantine on mortality in patients with major cognitive disorders: A systematic review and meta‐analysis

  2025cites this paper
• MAPT mutation-induced behavioral variant frontotemporal dementia in an Asian patient: a multimodal biomarker case report resolving diagnostic challenges with Alzheimer’s disease

  2025cites this paper
• Executive function and the feasibility of clinical trials for frontotemporal dementia

  2025cites this paper
• Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN‐RND)

  2024cites this paper
• Amyloid-Induced Neurodegeneration: A Comprehensive Review through Aggregomics Perception of Proteins in Health and Pathology.

  2024cites this paper
• Treatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trials.

  2023cites this paper
• New Approaches to the Treatment of Frontotemporal Dementia

  2023cites this paper
• Evaluation of the effect of transcranial direct current stimulation on language impairments in the behavioural variant of frontotemporal dementia

  2022cites this paper
• Knowledge and Attitudes for the Management of Behavioral Variant of Frontotemporal Dementia

  2022cites this paper
• Completed Suicide by Firearm in an Individual With the Agrammatic Variant of Primary Progressive Aphasia: Case Report

  2022cites this paper
• A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia

  2022cites this paper
• Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network

  2021cites this paper
• Treatment of the behavioral variant of frontotemporal dementia: a narrative review

  2021cites this paper
• Behavioral Variant Frontotemporal Dementia: Diagnosis and Treatment Interventions

  2021cites this paper
• Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care

  2021cites this paper
• Pharmacotherapy for Frontotemporal Dementia

  2021cites this paper
• Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

  2020cites this paper
• Four-Repeat Tauopathies: Current Management and Future Treatments

  2020cites this paper
• Dementia and usage of N-methyl-d-aspartate receptor antagonists

  2020cites this paper
• Effectiveness of Pharmacological Interventions for Symptoms of Behavioral Variant Frontotemporal Dementia: A Systematic Review

  2020influential citation
• Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

  2020cites this paper
• Anti-dementia Medications: Specific Agents

  2020cites this paper
• Editorial: Back to the Future: On the Road Towards Precision Psychiatry

  2020cites this paper
• Electromagnetic Field: A Potential Innovative Treatment for Alzheimer’s Disease

  2020cites this paper
• Frontotemporal Dementia: Neuropathology, Genetics, Neuroimaging, and Treatments.

  2020cites this paper
• Dementia 6. Frontotemporal dementia: diagnosis, treatment and medical management

  2020cites this paper
• Frontotemporal dementia: diagnosis, treatment and medical management

  2020cites this paper
• Memantine for dementia.

  2019cites this paper
• Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication

  2019cites this paper
• An atypical presentation of frontotemporal dementia.

  2019cites this paper
• Frontotemporal dementia.

  2019cites this paper
• Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial

  2019cites this paper
• Precision Medicine for Frontotemporal Dementia

  2019cites this paper
• Toward a Glutamate Hypothesis of Frontotemporal Dementia

  2019cites this paper
• Frontotemporal Dementia: A Clinical Review

  2019cites this paper
• Burden of caregivers of patients with frontotemporal lobar degeneration – a scoping review

  2019cites this paper
• Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

  2019cites this paper
• Potential Treatment Strategies for Dementia With Pharmacological and Nonpharmacological Interventions

  2019cites this paper
• Challenges of a frontotemporal dementia patient

  2018cites this paper
• Overcoming apathy in frontotemporal dementia: challenges and future directions

  2018cites this paper
• Frontotemporal dementia in psychiatric practice: diagnostic and therapeutic aspects

  2018cites this paper
• Therapeutic trial design for frontotemporal dementia and related disorders

  2018cites this paper
• Frontotemporal dementia: latest evidence and clinical implications

  2018cites this paper
• A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia

  2018influential citation
• Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study

  2018cites this paper
• Precision medicine of frontotemporal dementia: from genotype to phenotype.

  2018cites this paper
• Variation in Placebo Effect Sizes in Clinical Trials of Oral Interventions for Management of the Behavioral and Psychological Symptoms of Dementia (BPSD): A Systematic Review and Meta-Analysis.

  2017cites this paper
• Inappropriate behaviors and hypersexuality in individuals with dementia: An overview of a neglected issue

  2017cites this paper
• Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)

  2017cites this paper
• Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review

  2017cites this paper
• The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer’s Disease, and Mild Cognitive Impairment

  2017cites this paper
• Frontotemporal Dementia.

  2017cites this paper
• Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

  2017cites this paper
• Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias.

  2017influential citation
• Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies

  2017cites this paper
• (PPA): non-fluent variant primary progressive aphasia (nfvPPA) and semantic variant primary progressive aphasia (svPPA). FTD also frequently overlaps clinically with three additional neurodegenerative diseases with profound motor deficits: corticobasal degeneration (CBD), progressive supranuclear pa

  2016cites this paper
• The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report.

  2016cites this paper
• Therapy and clinical trials in frontotemporal dementia: past, present, and future

  2016cites this paper
• A Clinical Guide to Frontotemporal Dementias.

  2016cites this paper
• The frontotemporal dementias.

  2015cites this paper
• Evaluating Behavior in Mouse Models of the Behavioral Variant of Frontotemporal Dementia: Which Test for Which Symptom?

  2015cites this paper
• Clinical Subtypes of Frontotemporal Dementia

  2015cites this paper
• A quandary of symptoms: A case study of inter-professionalism

  2015cites this paper
• Neuropsychiatric management of young-onset dementias.

  2015cites this paper
• Memantine for the treatment of frontotemporal dementia: a meta-analysis

  2015cites this paper
• Memantine for the treatment of frontotemporal dementia: a meta-analysis

  2015cites this paper
• Frontotemporal dementia and primary progressive aphasia, a review

  2014cites this paper
• Frontotemporal Lobar Degeneration: A Clinical Approach

  2014cites this paper
• Frontotemporal lobar degeneration: current perspectives

  2014cites this paper
• Diagnosis and Treatment of Corticobasal Degeneration

  2014cites this paper
• Severe hyponatremia and seizures secondary to psychogenic polydipsia in a case of frontotemporal dementia.

  2014cites this paper
• Frontotemporal dementia: diagnosis, deficits and management.

  2014cites this paper
• Pharmacological Treatments for Frontotemporal Dementias

  2014influential citation
• Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes

  2014influential citation
• Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation

  2014cites this paper
• Treatment of Frontotemporal Dementia

  2014cites this paper
• [Frontal variant of frontotemporal dementia].

  2014cites this paper
• Frontotemporal lobar degeneration: current perspectives

  2014cites this paper
• Hope abandoned: memantine therapy in frontotemporal dementia.

  2013cites this paper
• Tratamiento de la demencia

  2013cites this paper
• Behavioural-variant frontotemporal dementia: an update

  2013cites this paper
• Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial.

  2013cites this paper
• Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open‐label pilot study

  2013cites this paper
• Progress in Frontotemporal Dementia Research

  2013cites this paper
• The Advantages of FTD Drug Development ( Part 2 of FTD : The Next Therapeutic Frontier )

  2013cites this paper
• Prise en charge thérapeutique de la démence

  2013cites this paper
• Neuroleptic Equivalent Dose Differences and Behavioral and Psychological Symptoms of Dementia

  2013cites this paper
• Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

  2013cites this paper
• Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score

  2013cites this paper
• The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

  2013cites this paper
• Frontotemporal Dementia

  2013cites this paper
• Frontotemporal dementia

  2013cites this paper
• Young-Onset Dementia

  2013cites this paper
• De la maladie de Pick aux démences fronto-temporales

  2012cites this paper
• Treatment Options for Tauopathies

  2012cites this paper
• Disease-modifying therapies in frontotemporal lobar degeneration.

  2012cites this paper
• Prospective Evaluation of Behavioral Scales in the Behavioral Variant of Frontotemporal Dementia

  2012cites this paper
• [From Pick's disease to frontotemporal dementia].

  2012cites this paper
• α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

  2012cites this paper
• Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia

  2012cites this paper